Background and objective: This study investigated the duration of immediate respiratory effects of e-cigarette smoking (ECS) and tested the hypothesis that ECS has more prominent effects in asthmatics compared with healthy smokers (HS). Methods: Fifty-four smokers, 27 healthy (HS group) and 27 with intermittent asthma (mild asthma (MA) group) underwent a control session (no liquid, no resistor coil inside e-cigarette cartridge) and an experimental session of ECS using standardized puffing settings. Impulse oscillometry impedance (Z), resistance (R), reactance (X) and fractional exhaled nitric oxide (FeNO) were measured before and 0, 15 and 30 min after control and experimental sessions. Results: Control session revealed no significant changes. In the experimental session, immediately post-ECS, both groups exhibited a significant increase in respiratory system total impedance at 5 Hz (Z5) (P < 0.001), respiratory system resistance at 5 Hz (R5) (P < 0.001), respiratory system resistance at 10 Hz (R10) (P < 0.001), respiratory system resistance at 20 Hz (R20) (P < 0.05), resonant frequency (P < 0.001) and reactance area (P < 0.05). MA exhibited higher baseline values and a more prominent effect immediately after ECS compared with HS for Z5 (P = 0.022), R5 (P = 0.010) and R10 (P = 0.013). FeNO decreased significantly in both groups (P < 0.001); HS returned to baseline values in ≤15 min while the MA maintained significantly lower values for an additional 15 min (P < 0.05) and returned to baseline values at 30 min post-ECS. Conclusion: A single session of ECS had respiratory mechanical and inflammatory effects, which were more prominent in smokers with asthma.
INTRODUCTION
E-cigarette smoking (ECS) has been shown to be associated with respiratory symptoms, 1,2 immediate pulmonary dysfunction and oxidative stress expressed as increased flow resistance and reduced fractional exhaled nitrogen oxide (FeNO). 3 However, the time course of such alterations has not been previously examined and the duration of the immediate pulmonary effects of ECS is not known.
Furthermore, it is known that combustible cigarette smoking (CCS) has more inflammatory effects in smokers with asthma compared to healthy smokers (HS). 4, 5 Limited studies on the effects of ECS on asthma have shown increased asthma symptoms and severity. 1, 6 However, there has been no systematic comparison of the pulmonary effects of ECS between healthy people and those with asthma.
The current study investigated the duration of ECS pulmonary effects in smokers with and without asthma. In addition, the hypothesis that ECS has different immediate effects in smokers with asthma compared to HS was tested.
METHODS
Ethics approval was issued from the Hellenic Cancer Society (Protocol: 561/28-1-14). Participants read and signed an informed consent form before enrolment. Fiftyfour adults aged 18-35 years, dual smokers (ECS and CCS) were recruited; 27 healthy non-atopic smokers (HS group) and 27 smokers with mild, intermittent, wellcontrolled asthma (Global Initiative for Asthma (GINA) classification, mild asthma (MA) group). The MA had a physician diagnosis of MA treated only with short-acting β2-agonists when required. They reported atopic history and sporadic symptoms (dry cough, chest tightness and wheezing) elicited by exposure to certain triggers. MA participants completed an Asthma Control Test (ACT) 7 with reported scores ≥20; they were asymptomatic, free of medication 2 weeks prior and throughout the study. Measurements were performed outside the pollen season.
Current cigarette smoking was defined as smoking ≥1 cigarette during the past 30 days.
8 Experienced ecigarette smokers were defined as users of ≥1 mL of liquid/day with nicotine concentration ≥12 mg/mL, and use of their device for ≥3 months. 9 Exclusion criteria included acute or chronic disease (except mild intermittent asthma in MA), abnormal spirometry, recent infection (<4 weeks prior to study), obesity (BMI ≥30), pregnancy, lactation or any medication use.
Study design
All participants used the same new-generation ecigarette (adjustable voltage) and liquid with 12 mg/ mL nicotine concentration. Analysis of the e-liquid using gas and liquid chromatography-mass spectrometry techniques 10 showed it contained propylene glycol 46.13% w/v, glycerol 34.3% w/v, nicotine 1.18% w/v and tobacco essence (<5% w/v).
11
A Jaeger MasterScreen spirometry system (Franklin Lake, NJ, USA) 12 was used for spirometry, a Viasys Jaeger MasterScreen IOS (Franklin Lake, NJ, USA) for impulse oscillometry system (IOS) parameters 13, 14 and an Eco Medics AG CLD 88 Series chemiluminescence analyser (Durnten, Switzerland) for FeNO measurements. 15 Both IOS and FeNO were performed in three reproducible (intra-assay coefficient of variation (CV) < 10%) consecutive trials. 15 
Study protocol
All participants individually completed three consecutive sessions: screening, control (C) and experimental (E).
The screening session consisted of a medical history, ACT and baseline spirometry. IOS was preferred during C and E sessions as it captures finer dysfunction undetected by spirometry. 14, 16 During C sessions, participants, while seated, used the e-cigarette for 5 min without the liquid and resistor coil. As no vapour was produced in the control session, blind control was not possible.
During E sessions, participants, while seated, used the e-cigarette for 5 min with all cartridge components attached. The same settings were applied throughout the study for standardization: Cartridge resistance was set to 1.6Ω, battery voltage to 3.7 V and puff duration to 4 s. Each subject inhaled 10 puffs with 30-s interpuff intervals. 9, 17, 18 Subjects were instructed to avoid consuming food and beverages for four hours prior to each session 15 and to abstain from both CCS and ECS for 12 h before measurements. 19 Participants were supervised during the sessions for compliance with study protocol.
During C and E sessions, IOS 14, 20 A repeated measurement analysis of variance (ANOVA) test was used to evaluate the effects of e-cigarette, smoking and asthma. Time was employed as a within-subjects factor. The interaction effect of time with smoking and the interaction effect of time with asthma (MA vs HS) were tested using general linear models. All reported P-values were two-tailed and P < 0.05 was considered significant.
Bonferroni correction for multiple testing was applied for the comparisons made in the same group and for the same dependent variable as a post hoc procedure. There were six different comparisons among the various time points for every dependent variable in each study group. The analysis was conducted using SPSS statistical software (version 19.0 IBM SPSS statistical software, Armonk, NY, USA.).
RESULTS
Both groups were similar in terms of gender, age, BMI and pack-years (P > 0.05). MA exhibited significantly lower values than the HS during baseline spirometry for all parameters (P < 0.05) except for forced vital capacity (FVC; Table 1) .
Results of IOS measurements are displayed in Tables 2. Frequency dependence of resistance (fdr) and respiratory system reactance at 10 Hz (X10) exhibited an intra-assay CV > 10% in both baseline and comparative measurements and were therefore dropped from the analysis.
MA exhibited significantly higher baseline IOS values than the HS for respiratory system total impedance at 5 Hz (Z5), respiratory system resistance at 5 Hz (R5), respiratory system resistance at 10 Hz (R10) and resonant frequency (f res ; all P < 0.05) in both the control and experimental sessions. Baseline respiratory system resistance at 20 Hz (R20) was significantly higher in the MA than HS (P = 0.043) in the experimental session only, while baseline respiratory system reactance at 20 Hz (X20) and reactance area (AX) differed between groups (P < 0.05) in the control session only.
The control session showed no significant differences for IOS between tpre and tpost (t0, t15 and t30) in both groups (P > 0.05). Comparisons in the experimental session yielded significant differences (P < 0.05) for all IOS parameters in both groups, with the exception of respiratory system reactance at 5 Hz (X5). For X5, only the MA group exhibited significant (P < 0.05) changes over time.
After ECS, both groups showed a similar pattern of change over time. At t0, Z5, R5, R10, R20, f res and AX increased, while X20 decreased. All parameters gradually returned to baseline values at t15. At t0, a significant increase was found for Z5 by 9.09% in HS (P < 0.001) and 15.79% in MA (P < 0.001); R5 by 9.68% in HS (P < 0.001) and 13.51% in MA (P < 0.001); R10 by 6.90% in HS (P = 0.001) and 15.15% in MA (P < 0.001); R20 by 6.90% in HS (P = 0.033) and 9.09% in MA (P < 0.001); f res by 11.31% in HS (P = 0.001) and 13.47% in MA (P < 0.001); and AX by 37.50% in HS (P = 0.041) and 52.78% in MA (P < 0.001). At t0, X20 decreased significantly in the HS by 20% (P < 0.001) and MA by 37.5%, (P < 0.001).
X5 did not change from tpre to t0 in the HS (P = 0.999) while in the MA group X5 decreased significantly by 9.09% at t0 (tpre vs t0, P < 0.001) and returned to tpre values at t15 (tpre vs t15, P = 0.999).
In the comparison between groups, the MA group showed a significantly higher degree of change over time than the HS for Z5 (P = 0.022), R5 (P = 0.010) and R10 (P = 0.013) (Fig. 1A-C) .
FeNO values at tpre were not significantly different between groups (C-HS vs C-MA, P = 0.892 and E-HS vs E-MA, P = 0.587). FeNO showed no significant differences in the control session between tpre and tpost (t0, t15 and t30) for both groups (Table 3) .
In the E session, the HS exhibited a significant decrease of FeNO at t0 (tpre vs t0, P < 0.001) by 11.51%. This reduction lasted for ≤15 min (tpre vs t15, P = 0.999). For the MA, FeNO decreased at t0 (tpre vs t0, P < 0.001) by 19.6% and returned to tpre at t30 (tpre vs t30, P = 0.999) ( Table 3) . Although there was no significant difference in the degree of change between groups accounting for the asthma effect (P = 0.174), the MA did show a longer duration of the ECS effect. MA maintained significantly lower values at t15 (tpre vs t15; 0.013). MA returned to baseline values at t30, whereas the HS returned in half that time (Fig. 1D) .
DISCUSSION
This study examined, for the first time, duration of immediate IOS and FeNO alterations caused by ECS. We also evaluated acute respiratory responses in HS and mild asthmatic smokers using new e-cigarette devices and standardized puffing. All participants had a minimal smoking history to control for the effect of smoking-induced chronic airway inflammation and remodelling. MA used only short-acting β2-agonists when required (no medication >2 weeks prior to the study) in order to control for the effect of long-term anti-inflammatory medication and long-acting bronchodilators on bronchomotor tone and reflexes.
The acute mechanical effect post-ECS was similar in both groups in terms of increased impedance and resistance in all frequencies, signifying an obstructive pattern. The findings of the current study are in accordance with previous study results that found a significant increase in the aforementioned parameters among otherwise HS. 3 Total impedance (Z5) is given by the pressure-flow ratio at each frequency and is the sum of all forces that oppose the applied oscillations. 14, 16 It includes the resistive (R) and reactive components (X). 14, 21 In the present study, Z5 increased post-ECS in both groups, showing alterations in both R and X; total impedance was significantly higher in the MA than the HS for all time points in the experimental session. R20, which reflects the large airways resistance, 22 increased significantly in both groups indicating that larger airways were affected, suggesting that ECS caused upper airway irritation in HS and MA, leading to a calibre reduction and consequent increase of upper airways resistance. R5, which reflects total airway resistance, 14, 20 increased post-ECS in both groups and was found to be significantly higher in the MA than the HS, as was the case with R10. The increase of Z5, R5 and R10 is correlated with acute bronchoconstriction and reduction of airway calibre in healthy and individuals with asthma. 22 In this study, MA showed significantly higher values for Z5, R5 and R10 for all time points across the experimental session denoting a more intense obstructive response than the HS.
All three parameters, X5, f res and AX, have been proposed as markers of airway closure and peripheral Statistically significant differences after Bonferroni correction are in bold. † P-values for comparison of baseline (tpre) measurements between HS and MA. ANOVA, analysis of variance; AX, reactance area; ECS, e-cigarette smoking; f res , resonant frequency; HS, healthy smoker; IOS, impulse oscillometry system; MA, mild asthma; P, P-value from repeated measurements ANOVA; R5, respiratory system resistance at 5 Hz; R10, respiratory system resistance at 10 Hz; R20, respiratory system resistance at 20 Hz; t0, immediately after ECS; t15, 15 min after ECS; t30, 30 min after ECS; tpre, baseline; X5, respiratory system reactance at 5 Hz; X20, respiratory system reactance at 20 Hz; Z5, respiratory system total impedance at 5 Hz.
obstruction, expressing the ventilation inhomogeneity due to peripheral bronchoconstriction. 20 Decreased X5, and increased R5, f res and AX have been observed in asthma while not in healthy controls.
14 Increases in R5, R20 and f res , with a decrease in X5, have been observed in response to bronchoprovocation while the inverse changes were observed in response to bronchodilation.
14 Moreover, X5 is considered a sensitive index of hyperreactivity, with a 50% decrease of X5 correlating to a 20% forced expiratory volume in 1 s (FEV 1 ) reduction. 14 In the current study, both groups, in addition to increased central airway resistance after ECS also revealed a peripheral obstructive pattern. The MA, however, expressed this pattern more prominently, as they exhibited a significantly higher degree of changes for Z5, R5 and R10 than the HS and a significant decrease in X5 that was insignificant in the HS. These results complement previous findings that showed increased airway resistance (Raw) in HS and asthmatic smokers. 1 A study of lung cell exposure to e-cigarette ingredients including nicotine, showed dose-dependent dysfunction of the lung endothelial barrier, oxidative stress and inflammation. 23 Another study of asymptomatic smokers (CCS) with normal spirometry showed that IOS findings of distal lung dysfunction associated with in vivo lung inflammation could predict those smokers at risk for chronic obstructive pulmonary disease. 24 In the present study, IOS was able to capture the fine qualitative and quantitative differences in response to ECS between HS and MA. The more intense peripheral airway obstructive response displayed by the MA may have expressed the additive effects of ECS and hyperreactivity, resulting in a more intense bronchoconstriction as occurs with inhaled triggers of asthma. 25 An acute FeNO reduction was found after ECS in both groups, supporting previously published studies. 2, 3 Although FeNO showed no difference in baseline values between groups, the MA did show a higher percentage change immediately post-ECS and also exhibited a prolonged duration of the effect as compared with the HS group, suggesting a more intense reaction.
The current findings showed that even asymptomatic patients with intermittent asthma not requiring regular treatment are significantly and measurably affected by a single session of ECS. Although we were not aiming to directly compare ECS and CCS effects, these findings are similar to previous reports on CCS by Kougias et al. 26 who found the same FeNO and IOS alterations and Papaioannou et al. 4 who observed a prolonged inflammatory effect indicated by FeNO increase in patients with moderate persistent asthma. Bronchoconstriction leads to FeNO reduction through its mechanical effect on the NO output from the narrowed airways and could explain the reduction observed in this study as well. 15 Aside from nicotine, e-cigarette liquid usually contains glycerol, propylene glycol and various flavours considered safe for ingestion. 27, 28 However, their safety for inhalation and the possible additive or dosedependent effects remain to be determined in the long term. E-cigarette glycerol has been reported as a cause of lipoid pneumonia 29 while exposure to glycol-based fogs can provoke acute cough, dry throat and decreased lung function. 30 It is suggested that propylene glycol has irritative and inflammatory potential on the airways and lung 27, 30 and has been linked with mild airway obstruction even in non-asthmatic subjects exposed to propylene glycol mists. 27 Therefore, it is suggested that the glycerol and/or propylene glycolinduced acute inflammation and consequent bronchoconstriction led to the increased flow resistance and reduced FeNO observed in this study. The current study findings, that is peripheral and central airway obstruction accompanied by reduced FeNO values triggered by ECS, that persisted for 15-30 min and were self-reversed, can be interpreted as a mild inflammatory reaction of the respiratory system in both groups while more pronounced in asthmatics.
In conclusion, the present study provides evidence that a single session of ECS had immediate mechanical and inflammatory respiratory effects in HS and asymptomatic smokers with MA. These actions persisted for 15 (IOS) to 30 min (FeNO). The intensity and duration of these changes were more prominent in the individuals with MA.
